REPORTING OF COVID-19 IN HAEMOGLOBIN DISORDERS

The purpose of the registry is to collect clinical data on thalassaemia patients who have been infected with the SARS-CoV-2 virus.

Currently the effects of this infection in thalassaemia patients is not known. It is suspected that patients with low iron overload and with few or no vital organ complications are not in danger of having a worse clinical outcome than the general population. This, however, is not certain. Patients with complications such as heart disease, pulmonary hypertension, liver disease, diabetes may have more serious development during the course of the infection. This also is not known.

Such knowledge is important to be known since increased precautions for vulnerable patients and more timely treatment may be necessary.

We request that all treating doctors fill this questionnaire so that global data, and the experience of as high a number of cases is recorded and analyzed.

Information must be without patient identification.

This form is to be completed by a health care professional caring for patients with beta thalassaemia and documented coronavirus (COVID-19). Please complete the form after the patient has had COVID-19 for a long enough duration to experience partial or complete recovery, hospitalization, or death.

Obtain IRB approval before completing if this is in accordance to your country's regulation

Note: Data management, storage and transfer will be secured according to institutional policies. Data will be saved on excel spread sheet (>=128 bit key AES encryption) in password protected files on secure, password protected computers with updated antivirus/malware protection.

Question Title

* 1. Reporter Information

Name of person reporting the case

Email address of person reporting case

Name of physician providing care for the patient case if different from the reporting person

Name of center/practice providing care for thalassaemia

Question Title

* 2. Patient Information

Age of patient, in years

Question Title

* 3. Country of residence

Question Title

* 4. Gender

Male

Female

Other

Question Title

* 5. Race

White

Arab

Black and African American

Asian

Native American

Hispanic or Latino

Pacific islanders

Question Title

* 6. Ethnicity

State ethnic group if different from country of residence

Disease factors:

Question Title

* 7. Transfusion Dependent Thalassaemia

Beta thalassaemia major

Haemoglobin E beta thalassaemia transfusion dependent

Other transfusion dependent thalassaemia

Question Title

* 8. Non transfusion dependent beta thalassaemia

Thalassaemia intermedia

Haemoglobin E beta thalassaemia non transfusion dependent

Haemoglobin H disease

Other (please specify)

Question Title

* 9. Sickle Cell Disease

Sickle Cell Anemia (homozygous HbS)

Sickle/β0 thalassaemia

Sickle/β+ thalassaemia

Other types of SCD(please specify)

Question Title

* 10. Was the patient evaluated/diagnosed in a hospital Emergency Department?

Yes

Unknown

Question Title

* 11. Was the patient evaluated/diagnosed in the day transfusion centre?

Yes

Unknown

Question Title

* 12. How was the diagnosis confirmed?

By nasopharyngeal specimen using RT-PCR?

By other test

Please name the test

Question Title

* 13. Has the patient been hospitalized due to COVID-19?

Yes

Unknown

If yes, length of hospital stay in days

Thalassaemia & SCD Medications:

Question Title

* 14. Hydroxyurea

Yes

How long has the patient been taking this medication and what dosage

Question Title

* 15. Penicillin (currently)

Yes

Question Title

* 16. Desferrioxamine. If yes, what is the current regime?

Days per week

Daily dose

Question Title

* 17. Deferiprone. If yes, what is the current regime?

Yes

Days per week

Daily dose

Question Title

* 18. Deferasirox. If yes, what is the current regime?

Yes

Days per week

Daily dose

Question Title

* 19. Combination

Yes

What is the combination of iron chelating agents?

What is the current regime: days per week

Daily dose of drug 1

Daily dose of drug 2

Question Title

* 20. Insulin

Yes

Question Title

* 21. Thyroxin

Yes

Question Title

* 22. Oestrogen replacement

Yes

Question Title

* 23. Testosterone replacement

Yes

Question Title

* 24. Other treatment

Question Title

* 25. Did the patient take any NSAIDS during this COVID-19 infection?

Yes

If yes, please name the medication

Question Title

* 26. Were any of the above thalassaemia or SCD medications discontinued due to COVID-19?

Thalassaemia or SCD disease-related history, prior to the COVID-19 infection:

Question Title

* 27. Splenectomy

Yes

Age of splenectomy and indication

Question Title

* 28. Cardiac arrhythmias

Yes

Is the patient on medications? Specify

Question Title

* 29. Cardiac failure

Yes

Last ejection fraction before the onset of the infection

Question Title

* 30. Cirrhosis

Yes

Question Title

* 31. Liver failure

Yes

Question Title

* 32. Hepatocellular carcinoma

Yes

Question Title

* 33. Acute painful episodes

Yes

Is the patient on medications? Specify

Question Title

* 34. Stroke

Yes

Last TCD findings before the onset of the infection

Question Title

* 35. Acute chest syndrome

Yes

Question Title

* 36. Acute splenic sequestration crises

Yes

Question Title

* 37. G6PD deficiency

Yes

Question Title

* 38. Pulmonary hypertension

Yes

Last mPAP before the onset of the infection

Question Title

* 39. Sickle Cell hepatopathy

Yes

If Yes, please specify the type of hepatopathy

Question Title

* 40. Past Hepatitis C infection

Yes

Question Title

* 41. On-going Hepatitis C infection

Yes

If yes, is the patient currently on anti-viral therapy? If yes, please name the medication

Question Title

* 42. Past Hepatitis B infection

Yes

Question Title

* 43. Ongoing Hepatitis B infection

Yes

If yes, is the patient currently on anti-viral therapy? If yes, please name the medication

Question Title

* 44. Hypothyroidism

Yes

Question Title

* 45. Diabetes

Yes

Question Title

* 46. Current iron loading

Average serum ferritin over past year

Last liver iron concentration (if within past 12 months) mg/g dry wt

Last myocardial T2* (if within past 24 months) MS

Average pre-transfusion Hb over the last year

Number of blood transfusions (unit) in the month before infection with COVID-19

Have other cases of COVID-19 been reported from the patient’s usual treatment centre?

Does the patient have any of the following comorbidities? (for ages 19 or higher)

Question Title

* 47. Asthma

Yes

Question Title

* 48. Other Chronic Lung Disease (NOT asthma/COPD)

Yes

Question Title

* 49. Hypertension

Yes

Please list medication

Question Title

* 50. Cancer

Yes

Please specify

Question Title

* 51. Current cigarette smoker

Yes

Question Title

* 52. Past smoker (long term effects of smoking – related perhaps to ACE-2 enzyme)

Yes

Question Title

* 53. Other comorbidities

Year of COVID-19 diagnosis:

Question Title

* 54. Specify the approximate number of days from onset of symptoms to confirmed COVID-19 diagnosis

Question Title

* 55. What was the level of Hb at the time of diagnosis?

Question Title

* 56. White cell count at the time of diagnosis

The total of white cell count

The total of neutrophil count

The total of lymphocyte count

Question Title

* 57. Please choose a severity of COVID-19 category:

Asymptomatic-no clinical signs or symptoms during the positive COVID-19 period.

Mild- symptoms of acute upper respiratory tract infection, including fever, fatigue, myalgia, cough, sore throat, runny nose, and sneezing or gastrointestinal symptoms of digestive symptoms such as nausea, vomiting, abdominal pain and diarrhea.

Moderate-pneumonia, with or without clinical symptoms, no hypoxia

Severe-early respiratory symptoms or gastrointestinal symptoms followed by dyspnea and hypoxia (O2 saturations less than 92%)

Critical-ARDS, respiratory failure, encephalopathy, shock, coagulopathy, multi-organ impairment (lung, heart, kidney, brain) that may be life-threatening

Did patient develop any of these complications at the time of COVID-19 infection?

Question Title

* 58. Difficulty in breathing

Yes

Question Title

* 59. Liver failure

Yes

Question Title

* 60. Acute painful episode

Yes

Question Title

* 61. Pulmonary hypertension

Yes

Question Title

* 62. Heart arrhythmias

Yes

Question Title

* 63. Heart failure

Yes

Question Title

* 64. Kidney failure

Yes

Question Title

* 65. Bacterial infection

Yes

If yes, what organism?

Question Title

* 66. Have patient's symptoms resolved at the time of this report?

Yes

Unknown (lost to follow up)

Patient never developed symptoms (just tested positive)

Question Title

* 67. Did the patient require a ventilator?

Yes

Question Title

* 68. Did the patient receive blood transfusion, during the course of the infection?

Yes

Question Title

* 69. Was there a marked drop in Hb levels during the period of infection?

Yes

Question Title

* 70. Did patient die of COVID-19 or other complications caused by or contributed to by COVID-19?

Yes

Unknown